FU Na, ZHANG Haijing, LIU Aimei, LI Li. Clinical efficacy of monotherapy of pemetrexed disodium and docetaxel as second-line drug in the treatment of advanced non-small cell lung cancer and its toxic and side effects[J]. Journal of Clinical Medicine in Practice, 2017, (15): 78-80. DOI: 10.7619/jcmp.201715021
Citation:
|
FU Na, ZHANG Haijing, LIU Aimei, LI Li. Clinical efficacy of monotherapy of pemetrexed disodium and docetaxel as second-line drug in the treatment of advanced non-small cell lung cancer and its toxic and side effects[J]. Journal of Clinical Medicine in Practice, 2017, (15): 78-80. DOI: 10.7619/jcmp.201715021
|
FU Na, ZHANG Haijing, LIU Aimei, LI Li. Clinical efficacy of monotherapy of pemetrexed disodium and docetaxel as second-line drug in the treatment of advanced non-small cell lung cancer and its toxic and side effects[J]. Journal of Clinical Medicine in Practice, 2017, (15): 78-80. DOI: 10.7619/jcmp.201715021
Citation:
|
FU Na, ZHANG Haijing, LIU Aimei, LI Li. Clinical efficacy of monotherapy of pemetrexed disodium and docetaxel as second-line drug in the treatment of advanced non-small cell lung cancer and its toxic and side effects[J]. Journal of Clinical Medicine in Practice, 2017, (15): 78-80. DOI: 10.7619/jcmp.201715021
|